Janux Therapeutics Inc: Rising -67.08% from 52-Week Low, Can the Stock Stay Afloat?

Janux Therapeutics Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $71.71 on 12/05/24 and a low of $22.48 for the same time frame on 05/14/25.

52-week price history of JANX Stock

Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Janux Therapeutics Inc’s current trading price is -67.08% away from its 52-week high, while its distance from the 52-week low is 5.03%. The stock’s price range during the 52-week period has remained between $22.48 and $71.71. In the Healthcare sector, the company’s shares saw a trading volume of around 0.64 million for the day, which was evidently lower than the average daily volume of 0.96 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Janux Therapeutics Inc (JANX) has experienced a quarterly decline of -25.07% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.40B and boasts a workforce of 81 employees.

Making Sense of Trading Volume and Moving Average Data

Examining JANX’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for JANX stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.02.

JANX Stock Price Performance Analysis

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The index has shown a price loss of -55.90% this year. Over the last six months, there has been a stronger performance of -62.79%. The price of JANX fallen by 1.46% during the last 30 days period. For the last 5-days stocks have slided -8.98%.

Most Popular

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.